MTHFR rs7832666: Folate Metabolism and Homocysteine
The rs7832666 polymorphism is a single-nucleotide variant located within the MTHFR gene region on chromosome 1. Research has identified preliminary associations between this variant, variability in folate metabolism, and circulating plasma homocysteine levels. However, the overall clinical evidence for rs7832666 remains limited and it should be interpreted as an educational biomarker rather than a diagnostic marker.
What each genotype means
Typical folate metabolism
This genotype represents the most common form of the MTHFR gene at this position. Research indicates that individuals with this profile typically maintain standard enzyme activity levels for processing folate. Your folate status is primarily determined by your dietary intake rather than this specific genetic variant.
Carried by the majority of the global population, though frequencies vary significantly by ancestry.
Common variant carrier
You carry one copy of the variant allele, which is associated with a slight reduction in MTHFR enzyme activity compared to the CC genotype. This change is generally considered a normal variation in human genetics and does not typically require medical intervention. You should focus on maintaining adequate dietary folate intake and discuss any concerns about homocysteine levels with your healthcare provider.
This is a very common genotype, found in a significant portion of the global population across diverse ethnic groups.
Reduced enzyme activity
This genotype is associated with a thermolabile form of the MTHFR enzyme, which may show reduced activity and is linked to slightly higher plasma homocysteine levels in some studies. While this variant is common, it is not a disease-causing mutation and is not a reason to avoid folic acid or standard dietary folate. Please consult with your clinician or pharmacist regarding your nutritional needs and any questions about homocysteine management.
Estimated to be present in approximately 10-15% of North American Caucasians and over 25% of Hispanic populations, but is less common in individuals of African descent.
Genomic Context and the rs7832666 Variant
The single-nucleotide polymorphism rs7832666 is situated within the genomic boundary of the methylenetetrahydrofolate reductase (MTHFR) gene on the short arm of chromosome 1. MTHFR is best known in genetic research for common coding polymorphisms such as C677T (rs1801133) and A1298C (rs1801131), but surrounding non-coding and intronic loci like rs7832666 also capture genetic variation within the locus. This variant represents an allelic substitution involving standard nucleotide bases (commonly C and T alleles) cataloged in dbSNP. Unlike severe, rare loss-of-function mutations that cause classic inborn errors of metabolism, rs7832666 represents a common polymorphism found across many human populations. Because of its genomic location, researchers frequently evaluate rs7832666 alongside classic MTHFR haplotypes to determine whether it exerts independent regulatory effects on transcript expression or simply reflects linkage disequilibrium with other functionally characterized variants across the one-carbon metabolic pathway.
The Biological Role of the MTHFR Gene
The MTHFR gene encodes methylenetetrahydrofolate reductase, a vital rate-limiting enzyme in the one-carbon metabolic network. This enzyme catalyzes the conversion of 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate (5-MTHF). The resulting product, 5-MTHF, serves as the primary circulating form of folate in human blood and provides the methyl group necessary for remethylating homocysteine back into the essential amino acid methionine. Methionine is subsequently transformed into S-adenosylmethionine (SAM), the universal methyl donor required for DNA methylation, histone modification, neurotransmitter synthesis, and phospholipid production. When MTHFR enzymatic activity is compromised or altered, intermediate homocysteine may accumulate in circulation, while downstream methylation pathways can experience modest regulatory shifts. Nutritional factors, particularly the dietary intake of folic acid, vitamin B12, and vitamin B6, strongly influence this metabolic pathway and frequently outweigh subtle genetic variations in daily enzymatic efficiency.
Scientific Evidence and Biomarker Associations
Published association studies and catalog records classify the evidence linking rs7832666 directly to clinical outcomes as limited. Genome-wide and candidate gene analyses exploring one-carbon biomarkers have evaluated rs7832666 for statistical connections with plasma homocysteine concentration and circulating folate status. While some cohort analyses observe modest statistical shifts in homocysteine levels in carriers of the minor allele, these effect sizes are generally small and often attenuated when adjusting for baseline dietary folate consumption. Furthermore, major professional medical bodies, including the American College of Medical Genetics and Genomics (ACMG), have noted that testing for common MTHFR polymorphisms offers minimal clinical utility in routine disease risk evaluation. Independent clinical trials have not demonstrated that isolated non-coding variants like rs7832666 cause clinical thrombophilia, cardiovascular disease, or pregnancy complications on their own, highlighting the substantial gap between subtle biochemical associations and actionable clinical diagnoses.
Global Allele Frequencies and Distribution
The rs7832666 polymorphism is a frequent variant worldwide rather than a rare pathogenic mutation. According to large population reference databases like the Genome Aggregation Database (gnomAD) and catalog summaries, the minor allele frequency (MAF) spans between 15% and 35% across diverse global cohorts. Frequencies can vary moderately depending on continental ancestry, mirroring patterns seen across the broader MTHFR locus where regional haplotype structures differ among European, East Asian, South Asian, African, and Hispanic populations. Because the variant is carried in single or double copies by millions of healthy individuals globally, its presence is considered a standard feature of human genetic diversity. The widespread prevalence of both homozygous and heterozygous genotypes reinforces that possessing an alternative allele is not an inherited metabolic defect, but rather a normal polymorphic baseline.
Practical Implications and Clinical Guidance
Discovering an rs7832666 genotype on an exploratory consumer genetic report should not cause alarm. Because the scientific evidence connecting this specific SNP to health outcomes is limited, medical guidelines do not recommend altering clinical care, prescribing medications, or initiating specialized nutritional regimens based on this variant alone. Public health authorities, including the Centers for Disease Control and Prevention (CDC), emphasize that individuals with common MTHFR variants can successfully metabolize standard dietary folate and fortified folic acid. If you have questions regarding your homocysteine concentrations, cardiovascular wellness, or prenatal nutritional requirements, schedule a consultation with a licensed healthcare provider. A simple standard blood test measuring serum homocysteine and folate provides a direct, functional assessment of your metabolic state that genetic variant screening alone cannot deliver.
How common is this variant?
Minor allele frequency ranges between 15% and 35% across diverse global cohorts, making all three genotypes common worldwide.
Frequently asked questions
What does the MTHFR rs7832666 variant mean for my health?
The rs7832666 variant is a common genetic polymorphism with limited evidence linking it to minor variations in folate metabolism and plasma homocysteine levels. It is not considered a medical diagnosis or a disease-causing mutation. Most individuals carrying this variant lead healthy lives with normal metabolic function, especially when consuming adequate dietary B vitamins.
Can I still process standard folic acid if I have this variant?
Yes. Public health organizations such as the CDC confirm that individuals carrying common MTHFR variants can process all forms of folate, including folic acid. Getting adequate folic acid through diet or supplementation remains the most effective way to maintain healthy blood folate concentrations regardless of genotype.
Should I order a homocysteine blood test because of my rs7832666 genotype?
Genetic results alone do not automatically necessitate laboratory testing. If you or your physician have concerns regarding cardiovascular health, vascular history, or nutritional absorption, a clinician can determine whether measuring total plasma homocysteine is clinically appropriate. Homocysteine tests reflect actual biochemical status, which genetics cannot reliably predict on its own.
Does having the rs7832666 variant require specialized supplements?
No published clinical guidelines recommend expensive or specialized methylated vitamin supplements based solely on rs7832666 status. Standard balanced nutrition and standard multivitamin formulations containing folate are generally sufficient for the general population. Any decision to take high-dose vitamins should be discussed with a doctor or registered dietitian.
How does rs7832666 differ from MTHFR C677T (rs1801133)?
MTHFR C677T (rs1801133) is a widely studied coding variant that directly changes an amino acid in the MTHFR enzyme, reducing its stability. In contrast, rs7832666 is a surrounding variant with limited scientific evidence that has not demonstrated the same pronounced biochemical effects in clinical research.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7832666?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in MTHFR
Variant in the MTHFR locus frequently studied in association with folate metabolism and homocysteine levels.
MTHFR missense variant (c.1793G>A, p.Arg594Gln) commonly evaluated alongside canonical variants for folate metabolism and hyperhomocysteinemia predisposition.
Functional polymorphism influencing homocysteine dynamics and vascular endothelial recovery during high-intensity training.
Common variant (C677T) influencing folate metabolism and plasma homocysteine levels.
The C677T variant in the MTHFR gene is associated with reduced enzyme activity and mild hyperhomocysteinemia, particularly in individuals with low folate intake.
The MTHFR 677C>T (Ala222Val) variant encodes a thermolabile enzyme with reduced activity. While associated with elevated homocysteine levels in the presence of low folate, major professional guidelines (e.g., ACMG) advise against routine clinical testing for cardiovascular or thrombophilia risk due to lack of clinical utility.